Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction.
BMC Cancer
; 22(1): 686, 2022 Jun 22.
Article
in En
| MEDLINE
| ID: mdl-35729538
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoembryonic Antigen
/
Lung Neoplasms
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2022
Type:
Article
Affiliation country:
China